A Study of Barrett's Esophagus Patients to Investigate Quality of Life and Fear of Cancer, and Optimize a Risk Model Based on Biomarkers and New Technologies to Better Predict the Development of Cancer

Recruiting

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(9 sites)

Belgium

University Hospital Antwerp, Edegem, Antwerpen

Sint-Augustinus Hospital (ZAS), Wilrijk, Antwerpen

UZ Gent, Ghent

AZ Delta, Roeselare

Denmark

Rigshospitalet, Copenhagen

France

CHU LILLE - Centre Hospitalier Universitaire de Lille, Lille

Ireland

St James's Hospital, Dublin

Italy

IRCCS Ospedale San Raffaele, Milan, Milano

Sweden

Karolinska University Hospital, Solna